Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
"Despite headlines that the court was saving or preserving mifepristone, it did nothing of the sort," @JRubinBlogger writes. "Worse, Americans have plenty of reason to fear what the most radical and aggressive Supreme Court since "Dred Scott" is up to." https://t.co/lQmlLUJtwD
Read what biopharma executives think of the Supreme Court's decision to uphold FDA authority in abortion pill case. https://t.co/vQlaKZLopx
SCOTUS declining to review the FDA’s unwise treatment of abortion pills has nothing to do with endorsing abortion and everything to do with judicial restraint. Thanks @FDRLST for sharing my impressions. https://t.co/SW3FVTLi7d
The Supreme Court rejected a challenge on abortion pills, with various opinions emerging on the decision. It is seen as a move towards judicial restraint rather than an endorsement of abortion. Biopharma executives also weighed in on the decision.
